Flow Cytometry Market Size, Growth, Drivers & Opportunities | MarketsandMarkets

Flow Cytometry Market is projected to grow from USD 4.7 billion in 2022 to USD 6.9 billion by 2027, at a CAGR of 8.1% from 2022 to 2027 according to a new report by MarketsandMarkets™. The growth of the Flow Cytometry Market is largely driven by the rising prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research activities, increasing public-private initiatives in immunology and immuno-oncology research, and rising technological advancements in flow cytometry software.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

Browse in-depth TOC on "Flow Cytometry Market"

331 – Tables
37 – Figures
332 – Pages

Reagents & consumables segment held major share in Flow Cytometry Market in 2021.

Based on product & service, the market is segmented into reagents & consumables, instruments, software, services, and accessories. Reagents & consumables accounted for the largest share in the market in 2021. The large share of this segment can primarily be attributed to the growing use of flow cytometry techniques in clinical & research applications.

Research application segment dominated the global Flow Cytometry Market in 2021.

Based on applications, the market is segmented into research, clinical, and industrial applications.  In 2021, the research applications segment accounted for the largest share in the global market.  The large share of the research applications segment is mainly due to the growing adoption of flow cytometry in research activities and the increasing availability of flow cytometry services, such as cell sorting, cell cycle analysis, and apoptosis.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584

North America has registered fastest growth rate during the forecast period in Flow Cytometry Market

Geographically, the Flow Cytometry Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share in the global market in 2021. The large share of North America in the market is largely driven by the presence of key market players and increasing public-private initiatives for research activities. The market in the Asia Pacific region is expected to grow at the highest CAGR of 8.6% during the forecast period. The high growth rate of the APAC region can be attributed to the growing pharmaceutical industry; increasing participation of emerging markets in flow cytometry-based research; expansion of research infrastructure; and increasing public-private initiatives to boost advanced proteomics research in the region.

The prominent players in the Flow Cytometry Market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US). These companies have adopted organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leading positions in the market.

Metagenomic Sequencing Market Size, Share|2022-2027

 The Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields.

The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643

Market Segmentation:

Based on applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. The drug discovery segment accounted for the largest share of the market in 2021. The large share of this segment can be attributed to the increasing research activities for novel drug discovery and growing collaborations between market players, academic institutions, and pharmaceutical companies for drug development.

Based on products & services, the metagenomic sequencing market is segmented into reagents & consumables, instruments, services, and analysis & data interpretation solutions. The reagents & consumables segment accounted for the largest share of the market in 2021. Factors such as the development and commercialization of high-quality reagents and kits and the continuous requirement of sequencing reagents by end users are expected to drive the growth of this segment in the market.

Regional Analysis:

The market in the Asia Pacific is expected to register the highest growth rate during the forecast period, primarily due to the increasing financial support from public as well as private agencies, the increasing number of NGS-based research projects, increasing awareness about precision medicine, and the rising prevalence of chronic diseases.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=60408643

Top Key Players:

Some of the leading players operating in the metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK).

Urinary Catheters Market - Growth Drivers & Opportunities | MarketsandMarkets

 The growing prevalence of urinary incontinence, an increasing number of surgical procedures across the globe, high incidence of prostate cancer, and the favorable reimbursement scenario are the major factors driving the growth of this market.

The report Urinary Catheters Market is projected to reach USD 2.6 billion by 2025 from USD 2.0 billion in 2020, at a CAGR of 5.5% during the forecast period.

Ask for PDF Brochure: – https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=132934629

Market Segmentation:-

Based on products, the global Urinary Catheterization Market is segmented into indwelling catheters, intermittent catheters, and external catheters. Indwelling catheters accounted for the largest share of the urinary catheters market in 2019. These catheters are also widely used in high-acuity patient units, with critical care and intensive care units registering the highest usage of indwelling catheters. Growth in this market is largely driven by the cost-efficiency and high availability of indwelling catheters in the market.

By catheter type, the global Urinary Catheterization Market is segmented into coated and uncoated catheters. Coated catheters accounted for the largest share of the urinary catheters market in 2019. This segment is also expected to register the highest CAGR during the forecast period. Growth in this market is mainly driven by the various advantages associated with coated catheters, such as easier, more comfortable insertion, low risk of catheter-associated urinary tract infection, reduced risk of urethral
damage, and improved patient satisfaction.

Recent Developments:-

• In 2019, Bactiguard launched BIP Foley TempSensor. This enhanced the urinary catheters product portfolio of Bactiguard.
• In 2019, ConvaTec Group acquired Southlake Medical Supplies, Inc. (US). This acquisition helped to strengthen ConvaTec’s distribution of catheter-related supplies in the US.
• In 2018, Coloplast acquired IncoCare Gunhild Vieler GmbH (Germany). This acquisition helped strengthen the company’s position in Germany, primarily in home care continence supplies.

Regional Analysis:-

The urinary catheters market is segmented into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America was the largest regional market for urinary catheters in 2019.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=132934629

Key Market Players: -

The global Urinary Catheterization Market is highly consolidated. The prominent players operating in this market include B. Braun Melsungen AG (Germany), Boston Scientific Corporation (US), Coloplast Ltd. (Denmark), ConvaTec Inc. (UK), Becton, Dickinson and Company (US), Cardinal Health (US), Teleflex Incorporated (US), Wellspect HealthCare (US), and Cook Medical (US).

 

Breast Biopsy Market - Growth Drivers & Opportunities | MarketsandMarkets

 Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.

What the Market Looks Like?

The report Breast Biopsy Market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805

Market Segmentation: -

Based on the product, the breast biopsy market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products. In 2019, the biopsy needles held significant share of the market. The major share of this segment is primarily attributed to the rising incidence of breast cancer and the growing breast cancer diagnosis rate in developing countries.

Based on guidance, the Breast Biopsy Devices Market is segmented into image-guided biopsy and liquid biopsy. The liquid biopsy segment is further divided into NGS-based, PCR-based, and Microarray-based biopsy. Among these, the NGS-based biopsy segment is expected to register significant growth over the forecast period.

Based on type, the Breast Biopsy Devices Market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. In 2019, the needle breast biopsy held a major share of the breast biopsy market. Needle biopsy has replaced conventional excisional biopsy as the standard diagnostic procedure for breast cancer.

What Drives the Market?

The growth of the global market for Breast Biopsy is primarily influenced by the following factors:

1 Growing incidence of breast cancer
2 Increasing number of breast cancer screening programs
3 Increasing demand for minimally invasive and non-invasive procedures
4 Growing awareness regarding early detection of breast cancer
5 Improved reimbursement scenario

Regional Analysis: -

The breast biopsy market is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of the breast biopsy market in 2019.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=189011805

Top Key Players: -

The major players operating in the breast biopsy market are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), Illumina, Inc. (US), and Fluxion Biosciences Inc (US), among others.

 

Flow Cytometry Market Size, Growth, Drivers & Opportunities | MarketsandMarkets

Flow Cytometry Market is projected to grow from USD 4.7 billion in 2022 to USD 6.9 billion by 2027, at a CAGR of 8.1% from 2022 to 2027

Major Growth Driving Factors:

The growth of the Flow Cytometry Market is largely driven by the rising prevalence of HIV/AIDS and cancer, growing adoption of flow cytometry techniques in research activities, increasing public-private initiatives in immunology and immuno-oncology research, and rising technological advancements in flow cytometry software.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65374584

Browse in-depth TOC on "Flow Cytometry Market"

331 – Tables
37 – Figures
332 – Pages

Reagents & consumables segment held major share in Flow Cytometry Market in 2021.

Based on product & service, the market is segmented into reagents & consumables, instruments, software, services, and accessories. Reagents & consumables accounted for the largest share in the market in 2021. The large share of this segment can primarily be attributed to the growing use of flow cytometry techniques in clinical & research applications.

Research application segment dominated the global Flow Cytometry Market in 2021.

Based on applications, the market is segmented into research, clinical, and industrial applications.  In 2021, the research applications segment accounted for the largest share in the global market.  The large share of the research applications segment is mainly due to the growing adoption of flow cytometry in research activities and the increasing availability of flow cytometry services, such as cell sorting, cell cycle analysis, and apoptosis.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65374584

Regional Analysis:

North America has registered fastest growth rate during the forecast period in Flow Cytometry Market

Geographically, the Flow Cytometry Market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America accounted for the largest share in the global market in 2021. The large share of North America in the market is largely driven by the presence of key market players and increasing public-private initiatives for research activities. The market in the Asia Pacific region is expected to grow at the highest CAGR of 8.6% during the forecast period. The high growth rate of the APAC region can be attributed to the growing pharmaceutical industry; increasing participation of emerging markets in flow cytometry-based research; expansion of research infrastructure; and increasing public-private initiatives to boost advanced proteomics research in the region.

Top Key Players: -

The prominent players in the Flow Cytometry Market are Becton, Dickinson and Company (US), Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Agilent Technologies, Inc. (US), and Luminex Corporation (US). These companies have adopted organic and inorganic growth strategies, such as product launches and acquisitions, to maintain their leading positions in the market.

Isothermal Nucleic Acid Amplification Technology Market | Growing at a CAGR of 11.0%

 Factors such as the rising prevalence of infectious diseases and the introduction of newer pathogens, the need for prompt diagnosis, the increasing number of blood transfusions and donations, and the cost-benefits of INAAT are the key factors driving the market growth.

The Isothermal Nucleic Acid Amplification Technology/INAAT Market is expected to grow from USD 1.9 billion in 2019 to USD 3.3 billion by 2024, at a CAGR of 11.0% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=839

Market Segmentations:-

Based on the product, the INAAT market is segmented into assay, kits, and reagents, and systems. Assay, kits, and reagents segment are expected to account for the largest share of the INAAT industry in 2019, Based on the type, the global market is divided into TMA, LAMP, SDA, HAD, NASBA, and other technologies.

Based on application, the INAAT market is segmented into infectious disease diagnosis, blood screening, and other applications such as cancer diagnosis, cancer research, and laboratory research, which encompass cDNA preparation, whole-genome amplification (WGA), single-nucleotide polymorphism (SNP), and mutation analysis.

Based on the end user, the market is divided into hospitals, reference laboratories, academic and research institutes, and other end users.

Recent Developments:

• In 2019, Hologic (US) launched Aptima BV and Aptima CV/TV Assays
• In 2018, Grifols (Spain) ) launched Procleix Babesia assay
• In 2018, Tecan Trading AG (Switzerland) acquired Nugen Technologies (US) which helped the company to enhance its next-generation sequencing reagents portfolio. This development helped the company to accelerate its broad genomics strategy.
• In 2016, Eiken Chemicals (Japan) signed a distribution agreement with HUMAN (Germany), for distribution of loop-mediated isothermal amplification-based tuberculosis and malaria molecular diagnostic systems in the global market (except in Japan, China, Korea, Taiwan, and Thailand).

Regional Analysis:-

In 2019, North America is expected to account for the largest share of the global INAAT market, followed by Europe.

Request for Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=839

Top Key Players:-

The major companies in the global INAAT market include Grifols S.A. (Spain), Hologic, Inc. (US), Abbott Laboratories, Inc. (US), Becton, Dickinson & Company (US), and Meridian Bioscience (US).

 

Animal Wound Care Market - Global Growth Drivers & Opportunities | MarketsandMarkets

 Animal Wound Care Market is projected to grow from USD 1.2 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 7.3% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth in this market is driven by rising demand for animal food products, increasing companion animal market, and surging veterinary healthcare expenditure. However, an upsurge in pet care expenditures and the dearth of vet practitioners in developing markets are impeding the market's growth.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253831778

Browse in-depth TOC on "Animal Wound Care Market" 
245 – Tables 
46 – Figures 
267 – Pages

In this report, the animal wound care market is segmented on the basis of product, animal type, end users and region.

"Companion animals defined for the largest share in the animal wound care market by animals"

In 2021, companion animals for a larger share of the global market. The growth of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, the rising number of sports horses, and surging demand for pet insurance across the world.

"Veterinary hospitals and clinics accounted for the largest share in the animal wound care market by end user"

On the basis of end users, the market is segmented into veterinary hospitals and clinics and home care settings. The large share of this segment can be attributed to increasing companion animal population and rising pet care expenditure in emerging regions.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=253831778

"Based on Region, North America holds the largest share in the animal wound care market"

On the basis of region, the animal wound care market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America segment accounted for the largest share of the market in 2021 due to major players availability and advanced healthcare infrastructure.

Key Market Players:

The prominent players in the global animal wound care market are Medtronic PLC (Ireland), Elanco Animal Health (US), Virbac (France), B. Braun Melsungen AG (Germany), Dechra Pharmaceuticals (UK), Neogen Corporation (US), Jorgen Kruuse A/S (Denmark), Ethicon, Inc. (US), Sonoma Pharmaceuticals Inc. (US), Prima-Vet Inc. (US), Smith & Nephew PLC (UK), Jazz Medical, LLC (Ireland), Kericure Inc. (US), etc.

Related Reports:

Wound Care Biologics Market by Product (Biological Skin Substitutes, Topical Agents), Wound Type (Ulcers [Diabetic Foot, Venous, Pressure Ulcers], Surgical & Traumatic Wounds, Burns), End User (Hospitals, ASCs, Burn Centers) – Global Forecast to 2027

Veterinary Equipment and Supplies Market by Type (Consumables, Patient Monitors, Anesthesia, Infusion Pumps), Application (Surgical (Gynecology, Dental), Diagnosis), Animal (Companion, Bovines), End User (Hospitals, Clinics) - Global Forecast to 2027

 

 

Bioimpedance Analyzers Market: Increasing prevalence of lifestyle diseases

 The growth in bioimpedance analyzers market is attributed to the prevalence of lifestyle diseases such as obesity, increasing awareness on healthy lifestyles, and the growing number of fitness clubs, weight loss clinics, and sports rehabilitation centers.

The global Bioimpedance Analyzers Market size is projected to reach USD 767 million by 2026 from USD 429 million in 2021, at a CAGR of 10.2%.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=144536297

Market Segmentation:

Based on the product, the bioimpedance analyzers market is segmented into multi-frequency bioimpedance analyzers, single-frequency bioimpedance analyzers, and dual-frequency bioimpedance analyzers. In 2020, the multi-frequency bioimpedance analyzers segment accounted for the larger share of the bioimpedance analyzers market. The preference for multi-frequency bioimpedance analyzers is high among end users as they can be used for both segmental and whole-body measurement, unlike single-frequency bioimpedance analyzers.

Based on the modality, the bioimpedance analyzers market is segmented into wired bioimpedance analyzers and wireless bioimpedance analyzers. The wireless bioimpedance analyzers segment accounted for the largest market share in 2020. The advancements in and the growing demand for wireless technologies are major driving factors for this market.

Based on end-users, the bioimpedance analyzers market is segmented into hospitals, fitness clubs and wellness centers, home users, and other end users. The fitness clubs and wellness centers segment accounted for the largest market share in 2020 due to the increasing number of fitness clubs and wellness centers, the growing awareness about health and fitness.

Regional Analysis:

The bioimpedance analyzers market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World. In 2020, North America accounted for the largest share of the bioimpedance analyzers market. The large share of North America can be attributed to factors such as the growing obesity rate, government initiatives to encourage healthy lifestyles, increasing use of body composition analyzers for assessing athlete fitness, and increasing number of health clubs and fitness centers.

Request for Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=144536297

Top key Players:

The major players in the bioimpedance analyzers market are Omron Corporation (Japan), Tanita Corporation (Japan), InBody (South Korea), RJL Systems (US), seca GmbH & Co. KG (Germany), EVOLT 360 (Australia), SELVAS Healthcare (South Korea), Charder Electronic Co. Ltd. (China), Fook Tin Group Holding Ltd. (China), Bodystat Ltd. (UK), Maltron International (UK), Biotekna (Italy), Withings (France), Biodynamics Corporation (US), Akern (Italy), Xiaomi (China), Sino-Hero (Shenzhen) Bio-Medical Electronics Co., Ltd. (China), Lumsail Industrial Inc. (China), Guangzhou Beautylife Electronic Technology Co., Ltd. (China), and Bioparhom (France).

 

Healthcare EDI Market: Increase in outsourcing of EDI services

 The growth of Healthcare EDI Market is majorly attributed to the development of regulations for transaction processes, the rising need to curtail healthcare costs and government support for HCIT implementation. Also, the need for the efficient management of electronic claims and reimbursement transactions (for healthcare providers) is expected to drive demand growth in the healthcare EDI market during the forecast period. EDI outsourcing is the process of having a third party manage a part or the entire process of using EDI to exchange data with trading partners.

The global Healthcare EDI market is projected to reach USD 4.4 billion by 2025 from USD 3.0 billion in 2020, at a CAGR of 7.8% during the forecast period.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=130571438

Market Segmentation:

Among the delivery mode segment, the mobile EDI segment is expected to grow at the highest CAGR during the forecast period. The factors attributing to the high growth of this segment include the technological upgrades in the healthcare industry and growing acceptance of mobile solutions among healthcare providers.

The services segment is expected to witness a faster growth rate in this market due to factors such as, the increasing claims volume, increasing complexity, and scale of EDI solutions, as they require extensive training programs. Similarly, a growing trend of outsourcing activities, such as revenue cycle management, claims handling and management, and partner management services is also expected to propel the growth of the services market.

On the basis of the transaction type, the EDI market is segmented into claims management and healthcare supply chain. The claims management segment is expected to account for the largest share of the market during the forecast period. The large share of this segment can be attributed to the rising adoption of EDI services by healthcare providers and payers and the need to meet regulatory requirements.

Based on end user, the healthcare EDI market is segmented into healthcare providers, healthcare payers, medical device & pharmaceutical industries, and pharmacies. The healthcare payers segment is expected to grow at the highest CAGR during the forecast period due to the increasing number of private insurance players in the market.

Regional Analysis:

North America is expected to hold the largest market size in the global market during the forecast period, followed by the European region. The rising HCIT expenditure, developed healthcare infrastructure, broad insurance coverage, a favorable regulatory scenario, an increasing number of private healthcare players, growing demand for healthcare supply chain management solutions, and the presence of prominent healthcare IT companies in this region, are responsible for the large share of the North American EDI market.

Request For Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=130571438

Top Key Players: -

McKesson Corporation (US), Optum (US), Allscripts Healthcare Solutions Inc. (US), athenahealth (US), and Nextgen Healthcare (US) are the key players operating in the healthcare EDI market. Other prominent players in this market include Cognizant Technology Corporation (US), SSI Group, LLC (US), Cerner Corporation (US), Comarch SA (Poland), Axway Software SA (France), Optum Inc. (US), Dell Technologies Inc. (US), Nextgen Healthcare (US), Synnex Corporation (US), Comarch (Poland), Axway Solutions (US), and Plexis Healthcare Systems (US).

Breast Biopsy Market: Growing incidence of breast cancer

 Technological advancements in the field of a breast biopsy and the rising incidence of breast cancer are the major factors driving the growth of this market. Additionally, the growing adoption of advanced techniques for breast cancer screening and rising government and private investments for improving breast cancer care are some of the other significant factors driving the growth of this market.

What the Market Looks Like?

The report Breast Biopsy Market is projected to reach USD 1,094 million by 2025 from USD 725 million in 2020, at a CAGR of 8.6% during the forecast period.

Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=189011805

Market Segmentation: -

Based on the product, the breast biopsy market is segmented into biopsy needles, guidance systems, biopsy tables, localization wires, assay kits, liquid biopsy instruments, and other products. In 2019, the biopsy needles held significant share of the market. The major share of this segment is primarily attributed to the rising incidence of breast cancer and the growing breast cancer diagnosis rate in developing countries.

Based on guidance, the Breast Biopsy Devices Market is segmented into image-guided biopsy and liquid biopsy. The liquid biopsy segment is further divided into NGS-based, PCR-based, and Microarray-based biopsy. Among these, the NGS-based biopsy segment is expected to register significant growth over the forecast period.

Based on type, the Breast Biopsy Devices Market is segmented into needle breast biopsy, open surgical breast biopsy, and liquid breast biopsy. In 2019, the needle breast biopsy held a major share of the breast biopsy market. Needle biopsy has replaced conventional excisional biopsy as the standard diagnostic procedure for breast cancer.

What Drives the Market?

The growth of the global market for Breast Biopsy is primarily influenced by the following factors:

1 Growing incidence of breast cancer
2 Increasing number of breast cancer screening programs
3 Increasing demand for minimally invasive and non-invasive procedures
4 Growing awareness regarding early detection of breast cancer
5 Improved reimbursement scenario

Regional Analysis: -

The breast biopsy market is segmented into five regional segments, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The North American region accounted for the largest share of the breast biopsy market in 2019.

Get Data as per your Format and Definition | REQUEST FOR CUSTOMIZATION: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=189011805

Top Key Players: -

The major players operating in the breast biopsy market are Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), Illumina, Inc. (US), and Fluxion Biosciences Inc (US), among others.

 

Endoscopic Retrograde Cholangiopancreatography Market Size and Share | 2022 - 2026 | MarketsandMarkets

 The growth of Endoscopic Retrograde Cholangiopancreatography Market is majorly attributed to factors such as the rising incidence of cancer, increasing investments by governments and healthcare organizations to improve endoscopy research, growing focus on investments by hospitals for advanced endoscopy instruments, and the increasing preference for minimally invasive surgeries. On the other hand, the high costs of endoscopic retrograde cholangiopancreatography devices, the development of other procedures like EUS and MRCP, and the shortage of trained physicians and endoscopists are factors expected to restrain the market growth to a certain extent.

The global endoscopic retrograde cholangiopancreatography market is projected to reach USD 2.0 billion by 2026 from USD 1.3 billion in 2021, at a CAGR of 9.6% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=170242954

Market Segmentation

Based on products, the ERCP market has been segmented into endoscopes, endotherapy devices, visualization systems, energy devices, and others. The factors attributing to the large revenue of the endotherapy devices segment include the growing preference for minimally invasive surgeries and the increasing prevalence of gastrointestinal conditions.

In the endotherapy devices segment, sphincterotomes accounted for the largest market share during the forecast period. This can be attributed to the increasing incidence of pancreatic duct and bile duct stones and the growing geriatric population leading to an increase in biliary disorders.

Regional Analysis:

North America accounted for the largest share of the ERCP market in 2020. The increasing prevalence of cancer, high investments by hospitals to purchase new ERCP equipment, and a strong focus on research activities to improve endoscopy techniques are the major factor contributing to this.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=170242954

Top Key Players:

The major players in the global endoscopic retrograde cholangiopancreatography market include Olympus Corporation (Japan), CONMED Corporation (US), Fujifilm Holdings Corporation (Japan), HOYA Corporation (Japan), KARL STORZ SE & Co. KG (Germany), Ambu A/S (Denmark), Boston Scientific Corporation (US), Johnson & Johnson (US), Medtronic, PLC (Ireland), Cook Medical (US), and B. Braun Melsungen AG (Germany).